{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T22:32:41Z","timestamp":1648938761833},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2011,5,18]],"date-time":"2011-05-18T00:00:00Z","timestamp":1305676800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nervenarzt"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1007\/s00115-010-2969-9","type":"journal-article","created":{"date-parts":[[2011,5,16]],"date-time":"2011-05-16T12:54:45Z","timestamp":1305550485000},"page":"707-711","source":"Crossref","is-referenced-by-count":0,"title":["Neuromuskul\u00e4re Signal\u00fcbertragung im Erwachsenenalter"],"prefix":"10.1007","volume":"82","author":[{"given":"A.","family":"Abicht","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Kr\u00f6ger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Schoser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,5,18]]},"reference":[{"key":"2969_CR1","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S0896-6273(00)80303-7","volume":"18","author":"Apel","year":"1997","unstructured":"Apel ED, Glass DJ, Moscoso LM et al (1997) Rapsyn is required for MuSK signaling and recruits synaptic components to a MuSK-containing scaffold. Neuron 18:623\u2013635","journal-title":"Neuron"},{"key":"2969_CR2","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jneuroim.2005.08.016","volume":"170","author":"Benveniste","year":"2005","unstructured":"Benveniste O, Jacobson L, Farrugia ME et al (2005) MuSK antibody positive myasthenia gravis plasma modifies MURF-1 expression in C2C12 cultures and mouse muscle in vivo. J Neuroimmunol 170:41\u201348","journal-title":"J Neuroimmunol"},{"key":"2969_CR3","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jneuroim.2006.05.017","volume":"177","author":"Boneva","year":"2006","unstructured":"Boneva N, Frenkian-Cuvelier M, Bidault J et al (2006) Major pathogenic effects of anti-MuSK antibodies in myasthenia gravis. J Neuroimmunol 177:119\u2013131","journal-title":"J Neuroimmunol"},{"key":"2969_CR4","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s12031-009-9229-0","volume":"40","author":"Engel","year":"2010","unstructured":"Engel AG, Shen XM, Selcen D, Sine SM (2010) What have we learned from the congenital myasthenic syndromes. J Mol Neurosci 40:143\u2013153","journal-title":"J Mol Neurosci"},{"key":"2969_CR5","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.jneuroim.2007.01.010","volume":"185","author":"Farrugia","year":"2007","unstructured":"Farrugia ME, Bonifati DM, Clover L et al (2007) Effect of sera from AChR-antibody negative myasthenia gravis patients on AChR and MuSK in cell cultures. J Neuroimmunol 185:136\u2013144","journal-title":"J Neuroimmunol"},{"key":"2969_CR6","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1097\/WCO.0b013e32833cc968","volume":"23","author":"Farrugia","year":"2010","unstructured":"Farrugia ME, Vincent A (2010) Autoimmune mediated neuromuscular junction defects. Curr Opin Neurol 23:489\u2013495","journal-title":"Curr Opin Neurol"},{"key":"2969_CR7","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S0092-8674(00)81252-0","volume":"85","author":"Glass","year":"1996","unstructured":"Glass DJ, Bowen DC, Stitt TN et al (1996) Agrin acts via a MuSK receptor complex. Cell 85:513\u2013523","journal-title":"Cell"},{"key":"2969_CR8","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/ana.22312","volume":"69","author":"Higuchi","year":"2011","unstructured":"Higuchi O, Hamuro J, Motomura M, Yamanashi Y (2011) Autoantibodies to low-density lipoprotein receptor-related protein 4 in myasthenia gravis. Ann Neurol 69:418\u2013422","journal-title":"Ann Neurol"},{"key":"2969_CR9","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/85520","volume":"7","author":"Hoch","year":"2001","unstructured":"Hoch W, McConville J, Helms S et al (2001) Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies. Nat Med 7:365\u2013368","journal-title":"Nat Med"},{"key":"2969_CR10","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.cell.2008.10.002","volume":"135","author":"Kim","year":"2008","unstructured":"Kim N, Stiegler AL, Cameron TO et al (2008) Lrp4 is a receptor for Agrin and forms a complex with MuSK. Cell 135:334\u2013342","journal-title":"Cell"},{"key":"2969_CR11","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1093\/brain\/awm068","volume":"130","author":"M\u00fcller","year":"2007","unstructured":"M\u00fcller JS, Herczegfalvi A, Vilchez JJ et al (2007) Phenotypical spectrum of DOK7 mutations in congenital myasthenic syndromes. Brain 130:1497\u20131506","journal-title":"Brain"},{"key":"2969_CR12","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1212\/01.WNL.0000072262.14931.80","volume":"60","author":"M\u00fcller","year":"2003","unstructured":"M\u00fcller JS, Mildner G, M\u00fcller-Felber W et al (2003) Rapsyn N88\u00a0K is a frequent cause of congenital myasthenic syndromes in European patients. Neurology 60:1805\u20131810","journal-title":"Neurology"},{"key":"2969_CR13","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.jneuroim.2008.05.030","volume":"15","author":"Palace","year":"2008","unstructured":"Palace J, Beeson D (2008) The congenital myasthenic syndromes. J Neuroimmunol 15:2\u20135","journal-title":"J Neuroimmunol"},{"key":"2969_CR14","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.nurt.2008.07.003","volume":"5","author":"Schara","year":"2008","unstructured":"Schara U, Lochm\u00fcller H (2008) Therapeutic strategies in congenital myasthenic syndromes. Neurotherapeutics 5:542\u2013547","journal-title":"Neurotherapeutics"},{"key":"2969_CR15","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.ajhg.2011.01.008","volume":"88","author":"Senderek","year":"2011","unstructured":"Senderek J, M\u00fcller JS, Dusl M et al (2011) Hexosamine biosynthetic pathway mutations cause neuromuscular transmission defect. Am J Hum Genet 88:162\u2013172","journal-title":"Am J Hum Genet"},{"key":"2969_CR16","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.neuron.2008.11.003","volume":"60","author":"Song","year":"2008","unstructured":"Song Y, Balice-Gordon R (2008) New dogs in the dogma: Lrp4 and Tid1 in neuromuscular synapse formation. Neuron 60:526\u2013528","journal-title":"Neuron"},{"key":"2969_CR17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jmb.2009.07.091","volume":"393","author":"Stiegler","year":"2009","unstructured":"Stiegler AL, Burden SJ, Hubbard SR (2009) Crystal structure of the frizzled-like cysteine-rich domain of the receptor tyrosine kinase MuSK. J Mol Biol 393:1\u20139","journal-title":"J Mol Biol"},{"key":"2969_CR18","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/0896-6273(95)90146-9","volume":"15","author":"Valenzuela","year":"1995","unstructured":"Valenzuela DM, Stitt TN, Distefano PS et al (1995) Receptor tyrosine kinase specific for the skeletal muscle lineage: expression in embryonic muscle, at the neuromuscular junction, and after injury. Neuron 15:573\u2013584","journal-title":"Neuron"},{"key":"2969_CR19","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.neuron.2008.10.006","volume":"60","author":"Zhang","year":"2008","unstructured":"Zhang B, Luo S, Wang Q et al (2008) LRP4 serves as a coreceptor of agrin. Neuron 60:285\u2013297","journal-title":"Neuron"}],"container-title":["Der Nervenarzt"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-010-2969-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00115-010-2969-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-010-2969-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T05:08:44Z","timestamp":1558588124000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00115-010-2969-9"}},"subtitle":["Aktuelle Facetten erworbener und angeborener St\u00f6rungen"],"short-title":[],"issued":{"date-parts":[[2011,5,18]]},"references-count":19,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["2969"],"URL":"https:\/\/doi.org\/10.1007\/s00115-010-2969-9","relation":{},"ISSN":["0028-2804","1433-0407"],"issn-type":[{"value":"0028-2804","type":"print"},{"value":"1433-0407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,5,18]]}}}